Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026
Electromed (NYSE American: ELMD) will report fiscal 2026 second quarter results for the period ended December 31, 2025 on Tuesday, February 10, 2026 after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International).
The live webcast of the call will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: Electromed Q2 Fiscal 2026 Webcast.
For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing Access ID 10206198. Additionally, a replay of the webcast will be available in the Investor Relations section of Electromed’s web site at: Events & Presentations
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127927448/en/
Brad Nagel, Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com
Mike Cavanaugh, Investor Relations
ICR Healthcare
(617) 877-9641
mike.cavanaugh@icrhealthcare.com
Source: Electromed, Inc.